Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 1
2003 1
2004 2
2005 3
2006 5
2007 4
2008 4
2009 2
2010 5
2011 8
2012 6
2013 12
2014 15
2015 11
2016 15
2017 16
2018 12
2019 11
2020 7
2021 17
2022 23
2023 31
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

194 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial.
Nakachi K, Ikeda M, Konishi M, Nomura S, Katayama H, Kataoka T, Todaka A, Yanagimoto H, Morinaga S, Kobayashi S, Shimada K, Takahashi Y, Nakagohri T, Gotoh K, Kamata K, Shimizu Y, Ueno M, Ishii H, Okusaka T, Furuse J; Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG). Nakachi K, et al. Among authors: yanagimoto h. Lancet. 2023 Jan 21;401(10372):195-203. doi: 10.1016/S0140-6736(22)02038-4. Lancet. 2023. PMID: 36681415 Clinical Trial.
Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial.
Morizane C, Okusaka T, Mizusawa J, Katayama H, Ueno M, Ikeda M, Ozaka M, Okano N, Sugimori K, Fukutomi A, Hara H, Mizuno N, Yanagimoto H, Wada K, Tobimatsu K, Yane K, Nakamori S, Yamaguchi H, Asagi A, Yukisawa S, Kojima Y, Kawabe K, Kawamoto Y, Sugimoto R, Iwai T, Nakamura K, Miyakawa H, Yamashita T, Hosokawa A, Ioka T, Kato N, Shioji K, Shimizu K, Nakagohri T, Kamata K, Ishii H, Furuse J; members of the Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG). Morizane C, et al. Among authors: yanagimoto h. Ann Oncol. 2019 Dec 1;30(12):1950-1958. doi: 10.1093/annonc/mdz402. Ann Oncol. 2019. PMID: 31566666 Free article. Clinical Trial.
Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study.
Ueno H, Ioka T, Ikeda M, Ohkawa S, Yanagimoto H, Boku N, Fukutomi A, Sugimori K, Baba H, Yamao K, Shimamura T, Sho M, Kitano M, Cheng AL, Mizumoto K, Chen JS, Furuse J, Funakoshi A, Hatori T, Yamaguchi T, Egawa S, Sato A, Ohashi Y, Okusaka T, Tanaka M. Ueno H, et al. Among authors: yanagimoto h. J Clin Oncol. 2013 May 1;31(13):1640-8. doi: 10.1200/JCO.2012.43.3680. Epub 2013 Apr 1. J Clin Oncol. 2013. PMID: 23547081 Clinical Trial.
Transarterial chemoembolization for liver metastases of a pancreatic neuroendocrine neoplasm: a single-center experience.
Nanno Y, Toyama H, Ueshima E, Sofue K, Matsumoto I, Ishida J, Urade T, Fukushima K, Gon H, Tsugawa D, Komatsu S, Kuramitsu K, Goto T, Asari S, Yanagimoto H, Kido M, Ajiki T, Fukumoto T. Nanno Y, et al. Among authors: yanagimoto h. Surg Today. 2023 Dec;53(12):1396-1400. doi: 10.1007/s00595-023-02714-9. Epub 2023 Jun 24. Surg Today. 2023. PMID: 37355500
Reinforced staplers for distal pancreatectomy.
Kawai M, Hirono S, Okada KI, Satoi S, Yanagimoto H, Kon M, Murakami Y, Kondo N, Sho M, Akahori T, Toyama H, Fukumoto T, Fujii T, Matsumoto I, Eguchi H, Ikoma H, Takeda Y, Fujimoto J, Yamaue H. Kawai M, et al. Among authors: yanagimoto h. Langenbecks Arch Surg. 2017 Dec;402(8):1197-1204. doi: 10.1007/s00423-017-1634-1. Epub 2017 Nov 4. Langenbecks Arch Surg. 2017. PMID: 29103084 Clinical Trial.
Central Pancreatectomy with Double Pancreaticojejunostomy.
Sho M, Akahori T, Nagai M, Satoi S, Yanagimoto H, Kinoshita S, Yamamoto T, Ikeda N, Kwon AH, Nakajima Y. Sho M, et al. Among authors: yanagimoto h. J Am Coll Surg. 2015 Aug;221(2):e15-9. doi: 10.1016/j.jamcollsurg.2015.05.004. Epub 2015 May 13. J Am Coll Surg. 2015. PMID: 26206657 No abstract available.
Space-Making Particle Therapy for Unresectable Hilar Cholangiocarcinoma.
Hashimoto Y, Komatsu S, Terashima K, Tsugawa D, Yanagimoto H, Suga M, Demizu Y, Tokumaru S, Okimoto T, Sasaki R, Ajiki T, Fukumoto T. Hashimoto Y, et al. Among authors: yanagimoto h. Dig Surg. 2022;39(2-3):99-108. doi: 10.1159/000524582. Epub 2022 Apr 22. Dig Surg. 2022. PMID: 35462363
Prognostic Impact of Inflammation-Based Scores for Extrahepatic Cholangiocarcinoma.
Asakura R, Yanagimoto H, Ajiki T, Tsugawa D, Mizumoto T, So S, Urade T, Nanno Y, Fukushima K, Gon H, Komatsu S, Kuramitsu K, Goto T, Asari S, Kido M, Toyama H, Fukumoto T. Asakura R, et al. Among authors: yanagimoto h. Dig Surg. 2022;39(2-3):65-74. doi: 10.1159/000521969. Epub 2022 Jan 20. Dig Surg. 2022. PMID: 35051946
The Usefulness of Total Tumor Volume as a Prognostic Factor and in Selecting the Optimal Treatment Strategy of Chemotherapeutic Intervention in Patients with Colorectal Liver Metastases.
Shimura Y, Komatsu S, Nagatani Y, Funakoshi Y, Sofue K, Kido M, Kuramitsu K, Gon H, Fukushima K, Urade T, So S, Yanagimoto H, Toyama H, Minami H, Fukumoto T. Shimura Y, et al. Among authors: yanagimoto h. Ann Surg Oncol. 2023 Oct;30(11):6603-6610. doi: 10.1245/s10434-023-13746-3. Epub 2023 Jun 29. Ann Surg Oncol. 2023. PMID: 37386304
194 results